Abstract
The synthesis of novel triazolyl 4-anilinoquinazolines in five sequential synthetic steps via copper-catalyzed click chemistry and their anticancer biological evaluation is described.
Similar content being viewed by others
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394
Garofalo A, Goossens L, Baldeyrou B, Lemoine A, Ravez S, Six P, David-Cordonnier MH, Bonte JP, Depreux P, Lansiaux A, Goossens JF (2010) Design, synthesis, and DNA-binding of N-alkyl(anilino)quinazoline derivatives. J Med Chem 53:8089
Garofalo A, Goossens L, Lemoine A, Ravez S, Six P, Howsam M, Farce A, Depreux P (2011) [4-(6,7-Disubstituted quinazolin-4-ylamino)phenyl] carbamic acid esters: a novel series of dual EGFR/VEGFR-2 tyrosine kinase inhibitors. MedChemComm 2:65
Garske AL, Peters U, Cortesi AT, Perez JL, Shokat KM (2011) Chemical genetic strategy for targeting protein kinases based on covalent complementarity. Proc Natl Acad Sci USA 108:15046
Giardina D, Martarelli D, Sagratini G, Angeli P, Ballinari D, Gulini U, Melchiorre C, Poggesi E, Pompei P (2009) Doxazosin-related α1-adrenoceptor antagonists with prostate antitumor activity. J Med Chem 52:4951
Hassan HMA (2018) A short and efficient total synthesis of ficuseptamines A and B. Molecules 23:1865
Hassan HMA, Brown FK (2010) A convenient approach to acyclic unsaturated amino acids via ring-closing metathesis. Chem Commun 46:3013
Hassan HMA, Denetiu I, Sakkaf K, Khan KA, Pushparaj PN, Gauthaman K (2017) Synthesis and biological evaluation of triazolyl monastrol analogues using Cu-catalyzed click chemistry. Heterocycles 94:1856
Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG (2013) Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 13:714
Kolb HC, Sharpless KB (2003) The growing impact of click chemistry on drug discovery. Drug Discov Today 8:1128
Lauria A, Delisi R, Mingoia F, Terenzi A, Martorana A, Barone G, Almerico AM (2014) 1,2,3‐Triazole in heterocyclic compounds, endowed with biological activity, through 1,3‐dipolar cycloadditions. Eur J Org Chem 2014:3289
Li F, Lu L, Liu P (2016) Acceptorless dehydrogenative coupling of o-aminobenzamides with the activation of methanol as a C1 source for the construction of quinazolinones. Org Lett 18:2580
Liu F, Barsyte-Lovejoy D, Allali-Hassani A, He Y, Herold JM, Chen X, Yates CM, Frye SV, Brown PJ, Huang J, Vedadi M, Arrowsmith CH, Jin J (2011) Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines. J Med Chem 54:6139
Odingo J, O’Malley T, Kesicki EA, Alling T, Bailey MA, Early J, Ollinger J, Dalai S, Kumar N, Singh RV, Hipskind PA (2014) Synthesis and evaluation of the 2,4-diaminoquinazoline series as anti-tubercular agents. Bioorg Med Chem 22:6965
Smits RA, Adami M, Istyastono EP, Zuiderveld OP, van Dam CM, de Kanter FJ, Jongejan A, Coruzzi G, Leurs R, de Esch IJ (2010) Synthesis and QSAR of quinazoline sulfonamides as highly potent human histamine H4 receptor inverse agonists. J Med Chem 53:2390
Thirumurugan P, Matosiuk D, Jozwiak K (2013) Click chemistry for drug development and diverse chemical–biology applications. Chem Rev 113:4905
VanBrocklin HF, Lim JK, Coffing SL, Hom DL, Negash K, Ono MY, Gilmore JL, Bryant I, Riese DJ (2005) Anilinodialkoxyquinazolines: screening epidermal growth factor receptor tyrosine kinase inhibitors for potential tumor imaging probes. J Med Chem 48:7445
Van Horn KS, Burda WN, Fleeman R, Shaw LN, Manetsch R (2014) Antibacterial activity of a series of N 2,N 4-disubstituted quinazoline-2,4-diamines. J Med Chem 57:3075
Verhaeghe P, Azas N, Gasquet M, Hutter S, Ducros C, Laget M, Rault S, Rathelot P, Vanelle P (2008) Synthesis and antiplasmodial activity of new 4-aryl-2-trichloromethylquinazolines. Bioorg Med Chem Lett 18:396
Yang Z, Wang T, Wang F, Niu T, Liu Z, Chen X, Long C, Tang M, Cao D, Wang X, Xiang W (2015) Discovery of selective histone deacetylase 6 inhibitors using the quinazoline as the cap for the treatment of cancer. J Med Chem 59:1455
Zhang J, Yang PL, Gray NS (2009) Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer 9:28
Acknowledgements
This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, under grant number G-203-141-1436. We, therefore, thank DSR for financial support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hassan, H.M.A., Denetiu, I., Khan, S.A. et al. Synthesis and biological evaluation of novel triazolyl 4-anilinoquinazolines as anticancer agents. Med Chem Res 28, 1766–1772 (2019). https://doi.org/10.1007/s00044-019-02413-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-019-02413-6